glp-1 vs sglt2 weight loss inhibitors or receptor agonists as second-line therapy in | VHRM SGLT2 inhibitors and GLP-1 receptor

Beinaglutide demonstrated significant advantages in weight reduction, but no significant differences were observed between the two groups in terms of improvements in liver stiffness, HbA1c control, liver enzymes, and blood lipids

The clinic operates on a cash-pay model using compounded GLP-1 injections, not FDA-approved brand-name drugs

Hydration with electrolyte solutions restores these more effectively than plain water alone

Nature (2004) 428(6982):56974

Finally, such predictive models can be incorporated into data-driven decision support systems, which can inform patients about imminent hypoglycemia and ultimately about optimized dietary choices to improve glucose control